Phibro Animal Health Corporation — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $374M | ↑+20.9% | $27M | ↑+762.1% | 13.5% |
| 2025-09-30 | $364M | ↑+39.7% | $27M | ↑+280.3% | 14.1% |
| 2025-06-30 | $379M | ↑+38.6% | $17M | ↑+2190.4% | 8.9% |
| 2025-03-31 | $348M | ↑+32.1% | $21M | ↑+148.4% | 9.6% |
| 2024-12-31 | $309M | ↑+23.7% | $3M | ↑+150.0% | 8.3% |
| 2024-09-30 | $260M | ↑+12.6% | $7M | ↑+187.0% | 6.8% |
| 2024-06-30 | $273M | ↑+7.1% | $752K | ↓-93.5% | 6.7% |
| 2024-03-31 | $263M | ↑+7.1% | $8M | ↓-16.3% | 7.6% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 55 quarters
margin trajectory tells the operating-leverage storyGo deeper
PAHC Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyPAHC Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics